Department of Cardiology, Copenhagen University Hospital, University of Copenhagen, Niels Andersens Vej 65, post-635, 2900 Hellerup, Gentofte, Denmark.
Europace. 2013 Aug;15(8):1150-7. doi: 10.1093/europace/eut017. Epub 2013 Feb 13.
To evaluate the incidences of and risk factors predisposing to appropriate and inappropriate shocks and mortality in a 'real-world' population of patients with ischaemic heart disease (IHD) and implantable cardioverter defibrillators (ICD) for primary prevention of sudden cardiac death (SCD).
In this nationwide cohort, we prospectively followed 1609 patients with IHD and left ventricular dysfunction from the Danish ICD Register who received an ICD for primary prevention of SCD (1 January 2007 to 30 November 2011). Primary study outcomes were appropriate shocks, inappropriate shocks, and all-cause mortality. Secondary study outcomes included the composite endpoints: appropriate therapy and inappropriate therapy (defined as shock or anti-tachycardia pacing). All-cause mortality was 12.1% during a mean follow-up time of 1.9 ± 1.3 years. Inappropriate shocks and therapy occurred in 2.6% and 3.7% during follow-up, respectively. Appropriate shocks and therapy was identified in 7.8% and 13.4%, respectively. Time-dependent multivariable Cox regression analyses were used to identify risk factors of inappropriate/appropriate shock, therapy and mortality. Implantation of a dual-chamber ICD was associated with increased risk of both inappropriate shocks and any inappropriate therapy compared to single-chamber ICD [hazard ratios (HR) = 2.45; confidence intervals (CI):1.16-5.14 and HR = 2.38; CI:1.28-4.42, respectively]. No excess risk of mortality was associated with any device type.
In this nationwide study of IHD patients with an ICD for primary prevention of SCD, the incidence of appropriate shocks as well as inappropriate shocks were significantly lower than reported in randomized trials. Implantation of a dual-chamber ICD was associated with more inappropriate shocks compared with single chamber devices.
评估在缺血性心脏病(IHD)和植入式心脏复律除颤器(ICD)的“真实世界”人群中,导致适当和不适当电击以及死亡率的发生率和危险因素,这些患者接受 ICD 是为了预防心脏性猝死(SCD)。
在这项全国性队列研究中,我们前瞻性地随访了来自丹麦 ICD 登记处的 1609 名 IHD 和左心室功能障碍患者,他们因 SCD 的一级预防而接受了 ICD(2007 年 1 月 1 日至 2011 年 11 月 30 日)。主要研究结果是适当的电击、不适当的电击和全因死亡率。次要研究结果包括复合终点:适当的治疗和不适当的治疗(定义为电击或抗心动过速起搏)。在平均 1.9 ± 1.3 年的随访期间,全因死亡率为 12.1%。在随访期间,分别有 2.6%和 3.7%的患者发生不适当的电击和治疗。分别有 7.8%和 13.4%的患者发生适当的电击和治疗。使用时间依赖性多变量 Cox 回归分析来确定不适当/适当电击、治疗和死亡率的危险因素。与单腔 ICD 相比,植入双腔 ICD 与不适当电击和任何不适当治疗的风险增加相关[风险比(HR)=2.45;置信区间(CI):1.16-5.14 和 HR = 2.38;CI:1.28-4.42]。任何设备类型均与死亡率的增加无关。
在这项针对 IHD 患者 ICD 一级预防 SCD 的全国性研究中,适当电击的发生率以及不适当电击的发生率明显低于随机试验报告的结果。与单腔装置相比,植入双腔 ICD 与更多的不适当电击相关。